Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
CytomX Therapeutics
Lyell Immunopharma, Inc.
Zai Lab (Hong Kong), Ltd.
Bristol-Myers Squibb
Nektar Therapeutics
Provectus Pharmaceuticals
University of Michigan Rogel Cancer Center
Celgene
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
University of Rochester
Case Comprehensive Cancer Center
Columbia University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute